| 1 |
European Guidelines for Obesity Management in Adults
Volkan Demirhan Yumuk, Constantine Tsigos, Martin Fried et al. · Obesity Facts
Open access |
2015 |
3,432 |
| 2 |
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean‐Frédéric Colombel et al. · The Lancet
|
30 Oct 2017 |
931 |
| 3 |
East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
Johan M. Burisch et al. · Gut
Open access |
20 Apr 2013 |
432 |
| 4 |
Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
Johan M. Burisch et al. · Gut
Open access |
23 Jan 2018 |
297 |
| 5 |
DNA methylation pattern in human zygotes and developing embryos
J. Fulka, Milan Mrazek, Olga Tepla et al. · Reproduction
|
Dec 2004 |
224 |
| 6 |
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Johan M. Burisch et al. · The Lancet. Gastroenterology & hepatology
Open access |
2 Mar 2023 |
205 |
| 7 |
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature
Dana Ďuricová, Johan M. Burisch, Tine Jess et al. · Journal of Crohn s and Colitis
|
18 Jun 2014 |
192 |
| 8 |
Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group
Bo Shen et al. · The Lancet. Gastroenterology & hepatology
Open access |
16 Jan 2020 |
181 |
| 9 |
Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006
A. Bortoli, N Pedersen, Dana Ďuricová et al. · Alimentary Pharmacology & Therapeutics
|
4 Aug 2011 |
181 |
| 10 |
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial
Walter Reinisch, Sieglinde Angelberger, Wolfgang Petritsch et al. · Gut
Open access |
13 May 2010 |
175 |
| 11 |
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study
Johan M. Burisch et al. · The Lancet. Gastroenterology & hepatology
Open access |
13 Feb 2020 |
167 |
| 12 |
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study
Johan M. Burisch et al. · Journal of Crohn s and Colitis
Open access |
2 Oct 2018 |
166 |
| 13 |
Geographic and age variations in mutational processes in colorectal cancer
Marcos Díaz‐Gay et al. · Nature
Open access |
23 Apr 2025 |
162 |
| 14 |
Bile acid malabsorption in inflammatory bowel disease
Martin Leníček, Dana Ďuricová, Viktor Komárek et al. · Inflammatory Bowel Diseases
|
7 Nov 2010 |
130 |
| 15 |
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial
Silvio Danese et al. · The Lancet. Gastroenterology & hepatology
Open access101 authors |
Feb 2022 |
129 |
| 16 |
Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO
Vito Annese, Dana Ďuricová, Corinne Gower‐Rousseau et al. · Journal of Crohn s and Colitis
|
31 Oct 2015 |
116 |
| 17 |
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort
Zsuzsanna Végh et al. · Journal of Crohn s and Colitis
Open access |
3 Jul 2014 |
107 |
| 18 |
eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in C rohn's disease
Natalia Pedersen, Margarita Elkjær, Dana Ďuricová et al. · Alimentary Pharmacology & Therapeutics
|
12 Sep 2012 |
102 |
| 19 |
Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s Disease
Torsten F. Kucharzik et al. · Clinical Gastroenterology and Hepatology
Open access |
13 Jul 2022 |
101 |
| 20 |
Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children
Martin Bortlík, Dana Ďuricová, Naděžda Machková et al. · Inflammatory Bowel Diseases
|
9 Jan 2014 |
99 |
| 21 |
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
Silvio Danese et al. · The Lancet. Gastroenterology & hepatology
Open access254 authors |
17 Nov 2021 |
96 |
| 22 |
eHealth
Natalia Pedersen, Peter Thielsen, Lars Martinsen et al. · Inflammatory Bowel Diseases
Open access |
23 Sep 2014 |
93 |
| 23 |
Laparoscopic Sleeve Gastrectomy without an Over-Sewing of the Staple Line
Mojmir Kasalicky, David Michalský, Jitka Housova et al. · Obesity Surgery
|
22 Jul 2008 |
92 |
| 24 |
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation
Dana Ďuricová, Eva Dvořáková, Ondřej Hradský et al. · Inflammatory Bowel Diseases
|
20 Sep 2018 |
84 |
| 25 |
Sur la Notion de Projectivité
Solomon Marcus · Mathematical logic quarterly
|
1965 |
83 |
| 26 |
Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis
Klaudia Farkas et al. · Journal of Crohn s and Colitis
Open access |
21 Apr 2016 |
82 |
| 27 |
The natural history of Crohn’s disease in children: a review of population-based studies
Dana Ďuricová, Mathurin Fumery, Vito Annese et al. · European Journal of Gastroenterology & Hepatology
|
30 Sep 2016 |
81 |
| 28 |
Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers
Karin Malíčková, Irena Francová, Milan Lukáš et al. · Practical Laboratory Medicine
Open access |
23 Sep 2017 |
79 |
| 29 |
Longitudinal Changes in Body Composition in Patients After Initiation of Hemodialysis Therapy: Results From an International Cohort
Daniele Marcelli, Katharina Brand, Pedro Ponce et al. · Journal of Renal Nutrition
Open access |
28 Nov 2015 |
74 |
| 30 |
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
Raja Narayana Atreya, Stuart L Bloom, Franco Scaldaferri et al. · Journal of Crohn s and Colitis
Open access |
20 May 2016 |
73 |
| 31 |
Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study
Martin Bortlík, Naděžda Machková, Dana Ďuricová et al. · Scandinavian Journal of Gastroenterology
|
8 Jul 2013 |
72 |
| 32 |
Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry
Kseniya Dryahina, Patrik Španěl, Veronika Pospíšilová et al. · Rapid Communications in Mass Spectrometry
|
29 Jul 2013 |
71 |
| 33 |
Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group
Bo Shen et al. · The Lancet. Gastroenterology & hepatology
|
19 Apr 2021 |
69 |
| 34 |
IBD patients need in health quality of care ECCO consensus
Margarita Elkjær, Gabrielle Moser, Walter Reinisch et al. · Journal of Crohn s and Colitis
Open access |
10 Apr 2008 |
69 |
| 35 |
Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study
Henit A. Yanai et al. · Journal of Crohn s and Colitis
Open access |
27 Jul 2022 |
66 |
| 36 |
Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn’s disease and ulcerative colitis
Kseniya Dryahina, David Cecil Smith, Martin Bortlík et al. · Journal of Breath Research
|
7 Aug 2017 |
63 |
| 37 |
Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases
Karin Malíčková, Dana Ďuricová, Martin Bortlík et al. · Autoimmune Diseases
Open access |
2011 |
61 |
| 38 |
Failure of oocyte maturation: Possible mechanisms for oocyte maturation arrest
Milan Mrazek · Human Reproduction
|
30 Oct 2003 |
60 |
| 39 |
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
Laurent Peyrin‐Biroulet, Perttu E. T. Arkkila, Alessandro Armuzzi et al. · BMC Gastroenterology
ReviewOpen access |
8 Jun 2022 |
58 |
| 40 |
Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial
Jan Březina, Lukáš Bajer, Pavel Wohl et al. · Journal of Clinical Medicine
Open access |
22 Jun 2021 |
55 |
| 41 |
Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?
L. Frolová, Karel Smetana, Dana Borovská et al. · Inflammation Research
|
6 Mar 2009 |
55 |
| 42 |
Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical Centre
Martin Lukáš, Martin Lukas, K Malickova et al. · Journal of Crohn s and Colitis
Open access |
4 Jan 2020 |
54 |
| 43 |
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
Martin Bortlík, Dana Ďuricová, Naděžda Machková et al. · Scandinavian Journal of Gastroenterology
|
2 Sep 2015 |
54 |
| 44 |
Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease
Marin J. de Jong, Danielle Roosen, Juliette H. R. J. Degens et al. · Journal of Crohn s and Colitis
|
22 Nov 2018 |
51 |
| 45 |
Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity
Magda Bajzová, Michaela Kováčiková, M. Vítková et al. · Physiological Research
Open access |
2008 |
50 |
| 46 |
[Inter-disciplinary European guidelines on surgery of severe obesity].
Martin Fried, Vojtěch Hainer, Arnaud Basdevant et al. · PubMed
|
Apr 2008 |
49 |
| 47 |
Safety of Ustekinumab and Vedolizumab During Pregnancy—Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study
Katarína Mitrová, Barbora Pipek, Martin Bortlík et al. · Journal of Crohn s and Colitis
|
16 Jun 2022 |
48 |
| 48 |
Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre
M. Kolar, Dana Ďuricová, Martin Bortlík et al. · Digestive Diseases
|
2017 |
48 |
| 49 |
Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn’s Disease
Benjamin Pariente et al. · Gastroenterology
Open access |
28 May 2021 |
47 |
| 50 |
Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies
Renske W. M. Pauwels et al. · Clinical Gastroenterology and Hepatology
ReviewOpen access |
30 Apr 2021 |
42 |